Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Keywords

Oxidative stress, Senile plaques, Reactive oxygen species, Chemistry, Peptide

References

• Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis.Thomas Tegtmeyer — 1995
• Nitration of tau protein is linked to neurodegeneration in tauopathies.V. Mary Stewart — 2003
• Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s diseaseMoreno Quiroz., Juan Alberto — 2004
• 24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux*Karlygash Abildayeva, Paula J. Jansen, Veronica Hirsch‐Reinshagen — 2006
• Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical ReviewFawzia Adam — 2012
• The amyloid precursor protein: A biochemical enigma in brain development, function and diseaseNatalia N. Nalivaeva, Anthony J. Turner — 2013
• Role of oxidized amino acids in protein breakdown and stability.Earl R. Stadtman — 1995
• Progressive accumulation of amyloid-β oligomers in Alzheimer’s disease and APP transgenic mice is accompanied by selective alterations in synaptic scaffold proteinsEmiley Pham, Leslie Crews, Kiren Ubhi — 2010
• Rapid generation of dityrosine cross-linked Aβ oligomers via Cu-redox cycling.Adam P. Gunn, Blaine R. Roberts, Ashley I. Bush — 2012
• The case for rejecting the amyloid cascade hypothesisKarl Herrup — 2015
• Reactivity of the Hydroxyl Radical in Aqueous Solutions.Leon M. Dorfman, G.E. Adams — 1973
• Redox Proteomics Analysis of Brains from Subjects with Amnestic Mild Cognitive Impairment Compared to Brains from Subjects with Preclinical Alzheimer's Disease: Insights into Memory Loss in MCIChristopher D. Aluise, Renã A. S. Robinson, Jian Cai — 2011
• Human Diseases with Defects in Oxidative PhosphorylationHerman Bentlage, I.F.M. de Coo, H. ter Laak — 1995
• The effect of APOE genotype on brain levels of oxysterols in young and old human APOE ε2, ε3 and ε4 knock-in miceAndrew M. Jenner, Wei Ling Florence Lim, Mary Pei-Ern Ng — 2010
• Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.D. Allan Butterfield, Servet Yatin, S. Varadarajan — 1999
• Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?Daniela Puzzo, Ottavio Arancio — 2012
• Free radicals and antioxidants in human health: current status and future prospects.T.P.A. Devasagayam, Jai C. Tilak, Krutin K Boloor — 2004
• Evidence Linking Genetics, Environment, and Epigenetics to Impaired DNA Repair in Alzheimer's DiseaseFabio Coppedè, Lucia Migliore — 2010
• A genetic cause of Alzheimer disease: mechanistic insights from Down syndromeFrances K. Wiseman, Tamara Al‐Janabi, John Hardy — 2015
• η-Secretase processing of APP inhibits neuronal activity in the hippocampusMichael Willem, Sabina Tahirović, Marc Aurel Busche — 2015

Cited by

• Rosmarinic acid attenuates &bgr;‐amyloid‐induced oxidative stress via Akt/GSK‐3&bgr;/Fyn‐mediated Nrf2 activation in PC12 cellsClarissa Ribeiro, Prado Gilbertto — 2018
• Targeting Amyloid Aggregation: An Overview of Strategies and MechanismsJeffrey E. Barrett, Douglas H. Clements — 2018
• The neurotoxicity of nanoparticles: A bibliometric analysisKristiaan Borret, Katrijn Apostel — 2018
• Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly.裕實 大森, Ohmori Yujitsu — 2019
• The Ameliorating Effects of Bee Pollen on Scopolamine-Induced Cognitive Impairment in Mice.Yulan Liao, Ho Jung Bae, Jiabao Zhang — 2019
• Crystal structure of catena-poly[[[dichloridocopper(II)]-μ-tert-butyl N-methyl-N-[4-(6-[4-(pyridin-2-yl-κN)-1H-1,2,3-triazol-1-yl-κN 3]methyl-1,3-benzothiazol-2-yl)phenyl]carbamato] acetonitrile monosolvate]Alexandre Pocinho, Carine Duhayon, Emmanuel Gras — 2018
• A metallo pro-drug to target Cu(II) in the context of Alzheimer’s diseaseAmandine Conte‐Daban, Vinita Ambike, Régis Guillot — 2018
• The Antioxidative Function of Alpha-Ketoglutarate and Its ApplicationsShaojuan Liu, Liuqin He, Yao Kang — 2018
• Physicochemical Characterization and Functional Analysis of the Polysaccharide from the Edible Microalga Nostoc sphaeroidesHaifeng Li, Linnan Su, Sheng Chen — 2018
• The Antioxidant Content and Protective Effect of Argan Oil and Syzygium aromaticum Essential Oil in Hydrogen Peroxide-Induced Biochemical and Histological ChangesMeryem Bakour, Najoua Soulo, Nawal Hammas — 2018
• Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot StudyMorimasa Kato, Ryuji Ochiai, Kazuya Kozuma — 2018
• When nature’s robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologiesJulie A. Reisz, Alexander Barrett, Travis Nemkov — 2018
• Multi-Target Anti-Alzheimer Activities of Four Prenylated Compounds from Psoralea FructusQingxia Xu, Ying Hu, Guiyang Li — 2018
• Role of ASIC1a in A&bgr;‐induced synaptic alterations in the hippocampusDalila Mango, Robert Nisticò — 2018
• The Cu(II) affinity of the N-terminus of human copper transporter CTR1: Comparison of human and mouse sequences.Karolina Bossak‐Ahmad, Simon C. Drew, Ewelina Stefaniak — 2018
• Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.Yunxiaozhu Zheng, Xiaoming Qiang, Rui Xu — 2018
• Distinctive phosphoinositide- and Ca2+-binding properties of normal and cognitive performance–linked variant forms of KIBRA C2 domainMareike G. Posner, Abhishek Upadhyay, Rieko Ishima — 2018
• Ascorbate oxidation by Cu(Amyloid-β) complexes: determination of the intrinsic rate as function of alterations in the peptide sequence reveals key residues for ROS productionElena Atrián‐Blasco, Melisa del Barrio, Peter Faller — 2018
• Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.Amandine Conte‐Daban, Maryline Beyler, Raphaël Tripier — 2018
• Alzheimer’s disease hypothesis and related therapiesXiaoguang Du, Xinyi Wang, Meiyu Geng — 2018

Related papers

• Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaquesHeiko Braak, Eva Braak, Thomas G. Ohm — 1989
• [Alzheimer's disease: cellular and molecular aspects].Jean‐Noël Octave, Nathalie Pierrot — 2008
• Laboratory diagnostic tests for Alzheimer's disease.Khalid Iqbal, Gian P. Wang, Inge Grundke‐Iqbal — 1989
• Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.Dennis W. Dickson, J. Farlo, Peter Davies — 1988
• Histochemical similarity of senile plaque amyloid to apudamyloidJames M. Powers, Samuel S. Spicer — 1977
• Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's typeGianluigi Mancardi, Boleslaw H. Liwnicz, T. I. Mandybur — 2004
• Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.Sozos Ch. Papasozomenos — 1989
• A neuronal antigen in the brains of Alzheimer patientsBenjamin Wolozin, Alex Pruchnicki, Dennis W. Dickson — 1987